Sugammadex

Generic Name
Sugammadex
Brand Names
Bridion, Sugammadex Adroiq, Sugammadex Amomed, Sugammadex Fresenius Kabi, Sugammadex Mylan, Sugammadex Piramal
Drug Type
Small Molecule
Chemical Formula
C72H112O48S8
CAS Number
343306-71-8
Unique Ingredient Identifier
361LPM2T56
Background

Sugammadex is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery. Rocuronium bromide and vecuronium bromide are neuromuscular blocking medications that cause temporary paralysis and are especially useful for general anesthesia, ventilation, or tracheal intuba...

Indication

Sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide or vecuronium bromide in adults and pediatric patients ≥2 years old who are undergoing surgery.

Associated Conditions
Neuromuscular blockade caused by vecuronium bromide
Associated Therapies
-

Sugammadex and Decreased Time to Extubation

First Posted Date
2017-06-22
Last Posted Date
2022-01-14
Lead Sponsor
Yale University
Target Recruit Count
90
Registration Number
NCT03196167
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients

First Posted Date
2017-05-30
Last Posted Date
2020-06-04
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
92
Registration Number
NCT03168308
Locations
🇺🇸

Parkland Health & Hospital System, Dallas, Texas, United States

Investigation of Sugammadex in Outpatient Urological Procedures

First Posted Date
2017-05-03
Last Posted Date
2020-09-22
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
54
Registration Number
NCT03138967
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant

Phase 3
Completed
Conditions
Interventions
First Posted Date
2017-04-17
Last Posted Date
2023-03-07
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
201
Registration Number
NCT03116997
Locations
🇺🇸

Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

🇺🇸

Memorial Sloan Kettering Commack, Commack, New York, United States

🇺🇸

Memoral Sloan Kettering Westchester, Harrison, New York, United States

and more 1 locations

Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery

Phase 4
Completed
Conditions
Interventions
First Posted Date
2017-04-13
Last Posted Date
2022-04-01
Lead Sponsor
University of Missouri-Columbia
Target Recruit Count
40
Registration Number
NCT03112993
Locations
🇺🇸

University on Missouri Hospital, Columbia, Missouri, United States

Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy

First Posted Date
2017-04-12
Last Posted Date
2019-04-29
Lead Sponsor
West Virginia University
Target Recruit Count
84
Registration Number
NCT03111121
Locations
🇺🇸

WVU Healthcare Ruby Memorial Hospital, Morgantown, West Virginia, United States

Comparison the Postoperative Quality of Recovery Between Neostigmine and Sugammadex in Elderly Patients Undergoing Trans Pars Plana Vitrectomy With General Anesthesia -Randomized Controlled Trial-

First Posted Date
2017-04-11
Last Posted Date
2017-11-17
Lead Sponsor
Yonsei University
Target Recruit Count
90
Registration Number
NCT03108989
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine, Seoul, Korea, Republic of

Neuromuscular Blockade During Transurethral Resection of Bladder Cancer

Phase 4
Completed
Conditions
Interventions
First Posted Date
2017-02-01
Last Posted Date
2018-05-22
Lead Sponsor
Seoul National University Bundang Hospital
Target Recruit Count
108
Registration Number
NCT03039543
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

Deep Neuromuscular Block for Laparoscopic Surgery

First Posted Date
2017-01-27
Last Posted Date
2020-04-22
Lead Sponsor
University of Melbourne
Target Recruit Count
350
Registration Number
NCT03034577
Locations
🇦🇺

Melbourne Health, Parkville, Victoria, Australia

🇦🇺

Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia

🇦🇺

The Royal Womens Hospital, Parkville, Victoria, Australia

and more 1 locations

Cerebral Oxygenation and Metabolism After Reversal Of Rocuronium: Comparison Between Sugammadex Versus Neostigmine

First Posted Date
2016-10-25
Last Posted Date
2018-10-19
Lead Sponsor
Mansoura University
Target Recruit Count
40
Registration Number
NCT02944175
© Copyright 2024. All Rights Reserved by MedPath